Ullink Launches MiFID II Trade Reporting Solution
Ullink, a global provider of electronic trading and connectivity solutions to the financial community, has launched its MiFID II compliant trade reporting solution to help its clients meet regulatory requirements for greater accuracy in reporting and timeliness of data collection.
Trade reporting reform is a core component of MiFID II. Under the new rules, details of all trades in eligible financial instruments (both equity and non-equity) need to be published to market participants in as close to real time as possible. In practice, for some instruments this means no later than 1 minute after the trade.
This move is posing significant challenges for market participants, illustrated in a recent survey conducted by WBR Research. The survey, which polled 150 equity traders in Europe, found 37% of respondents cited ‘post-trading issues’ as the factor expected to cause the biggest impact of MiFID II reforms.
With more than 15 years’ experience delivering trading solutions to capital markets firms, Ullink has fast-tracked the analysis of ESMA specifications to build an automated solution that will handle cross-asset class trade reporting requirements. The solution provides a central dashboard, providing status of reporting and ability to amend / cancel reports across multiple trade reporting venues operating under Approved Publication Arrangements (APAs). The solution includes Smart Report Routing logic for selecting amongst APAs based on business rules to optimise trade reporting costs.
Richard Bentley, Chief Product Officer at Ullink comments: “With MiFID II implementation drawing closer, there is increasing pressure on firms to deploy automated solutions for trade reporting that can apply the rules correctly, to eliminate possibility of over- or under-reporting. The changing APA landscape also focuses attention on centralised solutions which can process input from multiple front-office Order Management Systems, across asset classes. The new Ullink Trade Reporting solution is a powerful addition to Ullink’s portfolio, aimed at alleviating the burden of new regulations for post-trade workflows.”
Marketing & Communications Director
Tel.: +33 1 49 95 30 00
Tel: +44 (0)20 74269420
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ELLIOTT-MANAGEMENT-CORP23.3.2018 17:07 | pressemeddelelse
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:54 | pressemeddelelse
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:52 | pressemeddelelse
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets
JANSSEN23.3.2018 13:48 | pressemeddelelse
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)
AITHEON23.3.2018 13:02 | pressemeddelelse
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai
VIIV-HEALTHCARE23.3.2018 12:29 | pressemeddelelse
ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum